Skip to main content

Table 3 EAPP at baseline and end of treatment (VAS score, mm*) (n = 281).

From: Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials

 

Mean

Standard deviation

Minimum

25th percentile

Median

75th percentile

Maximum

Baseline

59.8

17.3

20

47

60

72

98

End of treatment

37.0

23.6

0

18

34

53

100

Change from baseline

-22.9

22.7

-93

-36

-20

-8

67

  1. *The VAS scores pain on a scale from 0 mm (absence of pain) to 100 mm (unbearable pain). A negative mean change in VAS score indicates a reduction in pain.